Schedule 13D ownership disclosure

THESEUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 88369M101

Event date: 2023-11-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-23-015548
Form type
SC 13D
Filer
TANG CAPITAL PARTNERS LP
CIK
CIK 1191935
Filed
Nov 24, 2023
Reporting period
Nov 14, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub